The Mental Health Mission (MHM), delivered through the Midlands Translational Centre (MTC), and funded by the National Institute of Health and Care Research is providing an exciting opportunity to help clinicians working in Midlands mental health trusts get involved in cutting edge research.
The aim of the Mental Health Mission is to develop innovative new treatments and technologies (£42.7 million funding boost for mental health research | NIHR). Within this the MHM:MTC aims to accelerate mental health research capacity in the Midlands to enhance access to novel interventions for early psychosis and difficult to treat depression.
This one-day training event will provide clinicians with an introduction to becoming a Principal Investigator on a clinical trial. We are inviting clinicians who are interested in taking on the role of Principal Investigator to attend the event with a representative from their R&D department, if possible. The event is free to attend and lunch and refreshments will be provided.
Visit the draft programme for further details.
Who can attend?
The event is aimed at clinicians who have not been Principal Investigators on a clinical trial before and who work with patients with early psychosis or depression and a representative from their Research & Development department. Multiple clinicians from a single trust may attend with one R&D representative.
Aims of the day
- To bring together clinicians working in mental health trusts who are interested in becoming a Principal Investigator (PI) on a clinical trial.
- To foster relationships with Midlands mental health trusts which may be part of current or future studies associated with the Mental Health Mission.
- To facilitate a dialogue and mutual support between potential PIs and R&D departments.
- To outline different types of trial design and standard processes involved within them.
- To identify the standard organisational structure of clinical trials and then apply this to sites.
- To outline the roles and responsibilities of PIs.
- To identify the infrastructure requitements for engaging in clinical trials and to develop actions for developing the infrastructure.
Learning Objectives/Outcomes
- Clinicians understand the key processes of clinical trials and know how they apply to their Trust.
- Clinicians and R&D representatives understand their respective roles in undertaking clinical trials.
- Clinicians and R&D representatives identify the infrastructure/support currently available in their Trust and what would need to be developed to undertake different types of clinical trial.
To register your interest, please complete the enquiry form.